Pheiron

Germany
Brackenheim, Baden-Wurttemberg, Germany

Company profile

Pheiron company profile

Pheiron provides a scalable, secure, and interoperable platform for deep data-driven health management. The company focuses on improving the probability of success in drug development by leveraging causal insights on targets and populations. Pheiron uses AI to map multimodal data to diseases, aiming to enhance the understanding of diseases and inform decision-making in drug development. The platform also supports large-scale exome sequence analysis to identify sex- and age-specific factors in health management.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-01-01, Year

Headquarters

Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$4.2M
Last funding
Series Unknown / $4.2M / 2025-06-20
Last equity funding
Series Unknown / $4.2M
Founders
2

Founders and investors

Founders

Jakob SteinfeldtThore Buergel